CYTEIR THERAPEUTICS INC's ticker is CYT and the CUSIP is 23284P103. A total of 38 filers reported holding CYTEIR THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $74,337 | -17.2% | 26,175 | -24.2% | 0.01% | -16.7% |
Q2 2023 | $89,794 | -67.2% | 34,536 | -77.0% | 0.01% | -60.0% |
Q1 2023 | $273,739 | -63.9% | 150,406 | -67.3% | 0.02% | -67.4% |
Q4 2022 | $758,636 | -40.3% | 459,779 | -25.5% | 0.05% | -24.6% |
Q3 2022 | $1,270,000 | +431.4% | 616,822 | +672.1% | 0.06% | +408.3% |
Q2 2022 | $239,000 | -39.6% | 79,884 | -24.0% | 0.01% | -25.0% |
Q1 2022 | $396,000 | -92.7% | 105,091 | -78.0% | 0.02% | -87.9% |
Q4 2021 | $5,429,000 | -46.6% | 477,510 | -17.6% | 0.13% | -35.3% |
Q3 2021 | $10,175,000 | -4.9% | 579,746 | +15.9% | 0.20% | +13.3% |
Q2 2021 | $10,700,000 | – | 500,000 | – | 0.18% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
OUP Management Co., LLC | 2,474,572 | $9,329,000 | 7.10% |
Novo Holdings A/S | 4,840,413 | $18,248,000 | 0.96% |
RA Capital Management | 3,350,506 | $12,631,000 | 0.28% |
Avidity Partners Management LP | 1,850,000 | $6,975,000 | 0.14% |
ACT CAPITAL MANAGEMENT, LLC | 15,000 | $57,000 | 0.06% |
Baker Brothers Advisors | 812,640 | $3,064,000 | 0.02% |
CAAS CAPITAL MANAGEMENT LP | 105,091 | $396,000 | 0.02% |
Evercore Wealth Management, LLC | 146,676 | $553,000 | 0.01% |
Jump Financial, LLC | 21,300 | $80,000 | 0.00% |
JANUS HENDERSON GROUP PLC | 1,719,610 | $6,486,000 | 0.00% |